CLINICAL_TRIALS trial_result · 2018-04-25

Clinical Trial Update: A Rheumatoid Arthritis Study in Participants [Phase 3]

Phase 3 rheumatoid arthritis trial conducted by Eli Lilly has completed and posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2018-04-25